T Lymphoblastic Leukemia/Lymphoma — Trials

T Lymphoblastic Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

140 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 12%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 48.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04582487	Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL	unknown	N/A	32	Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER	1	Feb 7, 2024	clinicaltrials
NCT04785833	CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia	unknown	N/A	20	PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY	1	Mar 8, 2021	clinicaltrials